Semiconductor Biochip Market Trends and Forecast
The future of the global semiconductor biochip market looks promising with opportunities in the medical, life science, pharmaceutical, and agricultural markets. The global semiconductor biochip market is expected to grow with a CAGR of 18.2% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine and point-of-care diagnostics, growing adoption of biochips in genomics and proteomics, and rising investments in healthcare infrastructure and research and development.
• Lucintel forecasts that active chip is expected to witness higher growth over the forecast period.
• Within this market, medical is expected to witness the highest growth.
• North America is expected to witness the highest growth over the forecast period.
Country Wise Outlook for the Semiconductor Biochip Market
• United States: Intel announced the development of a new semiconductor biochip for advanced medical diagnostics, aiming to commercialize by 2025. The government allocated $500 million for biochip research under the CHIPS Act, supporting domestic manufacturing and innovation.
• China: BGI Genomics launched a biochip designed for rapid disease detection, with a target of expanding its market share by 30% by 2026. The Chinese government is investing heavily in semiconductor biochip technology as part of its 14th Five-Year Plan.
• Germany: Siemens Healthineers announced a strategic partnership with local universities to develop biochips for personalized medicine, aiming for clinical trials by 2024. The German government introduced tax incentives to boost research and development in the semiconductor biochip sector.
• South Korea: Samsung Bioepis revealed plans to enter the semiconductor biochip market, targeting a 20% global market share by 2027. The South Korean government committed $1 billion to support biotech startups, focusing on innovative biochip technologies.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Semiconductor Biochip Market by Segment
The study includes a forecast for the global semiconductor biochip market by type, application, and region.
Semiconductor Biochip Market by Type [Value from 2018 to 2030]:
• Active Chips
• Passive Chips
Semiconductor Biochip Market by Application [Value from 2018 to 2030]:
• Medical
• Life Science
• Pharmaceutical
• Agricultural
• Others
Semiconductor Biochip Market by Region [Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Semiconductor Biochip Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies semiconductor biochip companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the semiconductor biochip companies profiled in this report include-
• Thermo Fisher Scientific
• Cellix
• GE Healthcare
• Randox
• Biodot
• Perkinelmer
• Roche
Recent Development in the Semiconductor Biochip Market
• Illumina and Pacific Biosciences Merger: In a significant move to consolidate the biochip market, Illumina announced its intention to acquire Pacific Biosciences for $1.2 billion. This merger aims to integrate Pacific Biosciences’ long-read sequencing technology with Illumina’s established short-read platform, enhancing the overall capabilities and applications of biochips in genomics.
• Thermo Fisher ScientificÄX%$%Xs Expansion: Thermo Fisher Scientific expanded its semiconductor biochip production capacity with the acquisition of Mesa Biotech for $450 million. This acquisition bolsters Thermo Fisher’s portfolio in rapid point-of-care molecular diagnostics, leveraging Mesa BiotechÄX%$%Xs biochip technology to enhance their product offerings in infectious disease testing.
• IBM’s AI-Enhanced Biochips: IBM introduced AI-enhanced biochips designed to accelerate drug discovery and personalized medicine. These biochips leverage artificial intelligence to analyze biological data more efficiently, offering faster and more accurate results in clinical diagnostics and pharmaceutical research.
• Bio-Rad LaboratoriesÄX%$%X Advancements: Bio-Rad Laboratories announced a breakthrough in its Droplet Digital PCR (ddPCR) technology, integrating advanced semiconductor biochips for more precise and scalable genetic analysis. This development is expected to significantly impact clinical diagnostics, especially in the detection of rare genetic mutations and infectious diseases.
• Agilent TechnologiesÄX%$%X New Product Launch: Agilent Technologies launched its latest line of semiconductor biochips, targeting the growing demand in clinical research and diagnostics. The new biochips are designed to provide high-throughput and cost-effective solutions for gene expression profiling, genotyping, and biomarker discovery, positioning Agilent as a leader in the biochip market.
Features of the Global Semiconductor Biochip Market
Market Size Estimates: Semiconductor biochip market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Semiconductor biochip market size by type, application, and region in terms of value ($B).
Regional Analysis: Semiconductor biochip market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the semiconductor biochip market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the semiconductor biochip market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for semiconductor biochip market?
Answer: The global semiconductor biochip market is expected to grow with a CAGR of 18.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the semiconductor biochip market?
Answer: The major drivers for this market are increasing demand for personalized medicine and point-of-care diagnostics, growing adoption of biochips in genomics and proteomics, and rising investments in healthcare infrastructure and research and development.
Q3. What are the major segments for semiconductor biochip market?
Answer: The future of the semiconductor biochip market looks promising with opportunities in the medical, life science, pharmaceutical, and agricultural markets.
Q4. Who are the key semiconductor biochip market companies?
Answer: Some of the key semiconductor biochip companies are as follows:
• Thermo Fisher Scientific
• Cellix
• GE Healthcare
• Randox
• Biodot
• Perkinelmer
• Roche
Q5. Which semiconductor biochip market segment will be the largest in future?
Answer: Lucintel forecasts that active chip is expected to witness higher growth over the forecast period.
Q6. In semiconductor biochip market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the semiconductor biochip market by type (active chips and passive chips), application (medical, life science, pharmaceutical, agricultural, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Semiconductor Biochip Market Market, Semiconductor Biochip Market Market Size, Semiconductor Biochip Market Market Growth, Semiconductor Biochip Market Market Analysis, Semiconductor Biochip Market Market Report, Semiconductor Biochip Market Market Share, Semiconductor Biochip Market Market Trends, Semiconductor Biochip Market Market Forecast, Semiconductor Biochip Market Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.